Encephalitis and antibodies to synaptic and neuronal cell surface proteins

Neurology

Volumn 77, Issue 2, 2011, Pages 179-189

  Lancaster, Eric ^d   Martinez Hernandez, Eugenia ^a,b   Dalmau, Josep ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AUTOANTIGEN; CELL SURFACE PROTEIN; CHOLINERGIC RECEPTOR ANTIBODY; CONTACTIN ASSOCIATED PROTEIN LIKE 2; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE RECEPTOR; GLYCINE RECEPTOR; IMMUNOGLOBULIN; LEUCINE RICH GLIOMA INACTIVATED 1; MEMBRANE ANTIGEN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE CELL ADHESION MOLECULE; RITUXIMAB; THYROID PEROXIDASE; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

AGITATION; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANXIETY; AUTOIMMUNITY; CANCER DIAGNOSIS; CANCER SCREENING; CATATONIA; CELL INFILTRATION; CELL SURFACE; CEREBELLAR ATAXIA; CEREBELLUM; CEREBROSPINAL FLUID EXAMINATION; COGNITIVE REHABILITATION; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DNA POLYMORPHISM; DYSTONIA; ENCEPHALITIS; FOLLOW UP; GENE MUTATION; GERM CELL TUMOR; HALLUCINATION; HIPPOCAMPUS; HODGKIN DISEASE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; IMMUNITY; IMMUNOTHERAPY; IN VIVO STUDY; INSOMNIA; IRRITABILITY; LIMBIC SYSTEM; MORTALITY; MOTOR DYSFUNCTION; MULTICENTER STUDY (TOPIC); MUTISM; MYOKYMIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PLASMAPHERESIS; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RIGIDITY; SEIZURE; SYNAPSE; SYNAPTIC TRANSMISSION; T LYMPHOCYTE; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 80051504636     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318224afde     Document Type: Review

References (40)

1. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-Nmethyl- D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36. (Pubitemid 46214241)
2. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009;65:424-434.
3. Lancaster E, Lai M, Peng X, et al. Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010;9:67-76.
4. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010;9:776-785.
5. Hutchinson M, Waters P, McHugh J, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 2008;71:1291-1292.
6. Dale RC, Irani SR, Brilot F, et al. N-Methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol 2009;66:704-709.
7. Tuzun E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 2007;13: 261-271. (Pubitemid 47396312)
8. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701-712. (Pubitemid 38295483)
9. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004;62:1177-1182. (Pubitemid 38456513)
10. Ances BM, Vitaliani R, Taylor RA, et al. Treatmentresponsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 2005;128: 1764-1777. (Pubitemid 41373648)
11. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDAreceptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-1098.
12. Irani SR, Bera K, Waters P, et al. N-Methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly nonparaneoplastic disorder of both sexes. Brain 2010;133: 1655-1667.
13. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74.
14. Pruss H, Dalmau J, Harms L, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 2010;75:1735-1739.
15. Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-Daspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009;66:11-18.
16. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010;10:835-844.
17. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010;30:5866-5875.
18. Kleinig TJ, Thompson PD, Matar W, et al. The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord 2008;23:1256-1261.
19. Manto M, Dalmau J, Didelot A, Rogemond V, Honnorat J. In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction. Orphanet J Rare Dis 2010;5:31.
20. Tuzun E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol 2009;118:737-743.
21. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia Brain 2010;133:2734-2748.
22. Boronat A, Sabater L, Saiz A, Dalmau J, Graus F. GABAB receptor antibodies in limbic encephalitis and anti-GAD associated neurological disorders. Neurology 2011;76: 795-800.
23. Vincent A. Antibodies to contactin-associated protein 2 (CASPR2) in thymoma and Morvan's syndrome. Ann Neurol 2009;66(suppl 13):S3.
24. Fukata Y, Lovero KL, Iwanaga T, et al. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci USA 2010; 107:3799-3804.
25. Zhou YD, Lee S, Jin Z, Wright M, Smith SE, Anderson MP. Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med 2009;15:1208-1214.
26. Yu YE, Wen L, Silva J, et al. Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitability. Hum Mol Genet 2010;19:1702-1711.
27. Geschwind MD, Tan KM, Lennon VA, et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt- Jakob disease. Arch Neurol 2008;65:1341-1346.
28. Barajas RF, Collins DE, Cha S, Geschwind MD. Adultonset drug-refractory seizure disorder associated with antivoltage- gated potassium-channel antibody. Epilepsia 2010;51:473-477.
29. Andrade Dm, Tai P, Dalmau J, Wennberg R. Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis. Neurology 2011;76:1355-1357.
30. + channels in myelinated axons depends on Caspr2 and TAG-1. J Cell Biol 2003;162: 1149-1160. (Pubitemid 37174196)
31. Lancaster E, Huijbers MG, Bar V, et al. Investigations of Caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2010;69:303-311.
32. Rubio-Agustí I, Perez-Miralles F, Sevilla T, et al. Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients. Neurology 2011;76:172-178.
33. Sillevis SP, Kinoshita A, De Leeuw B, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med 2000;342:21-27. (Pubitemid 30020656)
34. Mas N, Saiz A, Leite MI, et al. Antiglycine-receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry Epub 2010 Dec 10.
35. Titulaer MJ, Soffietti R, Dalmau J, et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force. Eur J Neurol 2011;18:19-e3.
36. Johnson N, Henry C, Fessler AJ, Dalmau J. Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology 2010;75:1480-1482.
37. Parratt KL, Allan M, Lewis SJ, Dalmau J, Halmagyi GM, Spies JM. Acute psychiatric illness in a young woman: an unusual form of encephalitis. Med J Aust 2009;191:284-286.
38. Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 2008;70:504-511. (Pubitemid 351653374)
39. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-1140. (Pubitemid 39005770)
40. Frechette ES, Zhou L, Galetta SL, Chen L, Dalmau J. Prolonged follow-up and cerebrospinal fluid antibody titers in a patient with anti-NMDA receptor encephalitis. Neurology 2011;76:S64-S66.